Gaël Jauvert

TL;DR: EDP measurements appear to identify potential candidates for CRT, and to confirm the success of system implantation, according to recipients of de novo CRT systems and patients with previously implanted standard pacing systems upgraded with the implantation of a left ventricular lead.

TL;DR: Multisite atrial pacing was conceived to correct, as much as possible, abnormal activation induced by spontaneous intra‐ or interatrial conduction disorders or by single site atrial paced, which are situations responsible for commonly refractory arrhythmias.

TL;DR: Pulmonary vein isolation using CF-guided RF and second-generation CB leads to comparable single-procedure arrhythmia-free survival at up to 18 months with similar overall complication rate.

TL;DR: This work has shown that atrial resynchronization by multisite atrial pacing may coutribute to prevention of recurrences in patients with drug‐refractory atrial tachyarrbythmias and significant intra‐atrial conduction delay.

TL;DR: CRT was technically feasible and associated with improvements in cardiac mechanical function and clinical status in patients with TGA, failing systemic RV, and intraventricular dyssynchrony.